Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001567619-22-013993

President and CEO sold 27,498 shares at $22.50 ($618,705)

  • President and CEO acquired 27,498 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Coulie Bernard · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-11 Exercise or conversion : show line 1 in the form +15,000 $2.08 $31,200 74,273 D
2022-07-11 Sale : show line 2 in the form −15,000 $22.50 $337,500 59,273 D
2022-07-12 Exercise or conversion : show line 3 in the form +12,498 $2.08 $25,996 71,771 D
2022-07-12 Sale : show line 4 in the form −12,498 $22.50 $281,205 59,273 D
Open-market sales · 27,498 sh · avg $22.50 · $618,705

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-07-11 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −15,000 322,380 D
2022-07-12 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −12,498 309,882 D
Loading xslF345X03/doc1.xml…